STOCK TITAN

Mirion Technologies Inc Stock Price, News & Analysis

MIR NYSE

Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.

Mirion Technologies Inc (MIR) delivers critical radiation safety solutions for nuclear energy, healthcare, and global security markets. This news hub provides investors and industry professionals with essential updates on the company developments shaping radiation detection technologies.

Access timely reports covering earnings announcements, product innovations, strategic partnerships, and regulatory milestones. Our curated collection features press releases and analysis on Mirion's Nuclear & Safety segment advancements and Medical division breakthroughs in cancer treatment safety.

Key updates include radiation monitoring system launches, international expansion efforts, and R&D initiatives addressing emerging nuclear safety challenges. Bookmark this page for structured access to operational updates from Mirion's global facilities and executive leadership commentary.

For stakeholders tracking radiation protection technologies, this resource offers comprehensive monitoring of Mirion's progress in dosimetry systems, environmental monitoring solutions, and medical radiation processing advancements. Return regularly for verified updates maintaining compliance with financial disclosure standards.

Rhea-AI Summary

Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at Citi’s 2023 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation is scheduled for 1:50 PM ET on Tuesday, February 21, 2023. A live webcast will be available at Mirion’s investor relations page, with an archived version accessible within twelve hours post-event.

About Mirion: Headquartered in Atlanta, GA, Mirion provides detection, measurement, and analysis solutions across nuclear, defense, medical, and research sectors, employing around 2,800 individuals globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Mirion Technologies (NYSE: MIR) will release its financial results for Q4 and fiscal year 2022 on February 14, 2023. A conference call will follow at 10:00 am ET to discuss these results. Participants can join the call by dialing 1-877-407-9208 or 1-201-493-6784, and a live webcast will be available at Mirion's investor website. A telephonic replay will be accessible until February 28, 2023, with details for accessing it provided. Mirion is a leader in detection and monitoring solutions in various end markets including nuclear and medical sectors, employing roughly 2,800 staff across 13 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.4%
Tags
conferences earnings
-
Rhea-AI Summary

Mirion Technologies, through its subsidiary Sun Nuclear, has designated Scripps Health as a Patient Safety Center of Excellence. This recognition highlights Scripps' leadership in Quality Management and Medical Physics in Radiation Therapy, with a focus on improving patient safety. Treating approximately 2,700 new patients annually in San Diego, Scripps aims to standardize and automate Quality Management workflows, enhancing efficiency. By leveraging Sun Nuclear's solutions, Scripps will guide other U.S. medical physics departments, thereby contributing to advancements in treatment protocols.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.94%
Tags
none
Rhea-AI Summary

Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the CJS Securities 23rd Annual New Ideas for the New Year Conference on January 11, 2023, at 3:45 PM ET. The presentation will be available via live webcast on their website, with an archive accessible within twelve hours post-event. Mirion specializes in detection, measurement, and monitoring solutions across various sectors, employing around 2,800 people globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.7%
Tags
conferences
-
Rhea-AI Summary

Mirion Technologies, Inc. (NYSE: MIR) has entered a definitive agreement to sell the physical medicine assets of Biodex Medical Systems, Inc. to Salona Global Medical Device Corporation for $5 million in cash and up to $3 million in deferred cash payments based on asset performance. These assets generated approximately $18 million in revenue with a gross margin of 30% in the last year. The deal is expected to close on December 31, 2022, allowing Mirion to focus on its core mission regarding ionizing radiation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.98%
Tags
none
-
Rhea-AI Summary

Mirion Technologies (MIR) reported third-quarter revenues of $160.9 million, an 11.5% increase from $144.3 million year-over-year. Despite this growth, the company faced a GAAP net loss of $50.4 million compared to a loss of $46.7 million in the prior year. Adjusted EBITDA decreased slightly to $30.8 million. Mirion anticipates organic adjusted revenue growth of 4% to 6% for 2022 alongside adjusted EBITDA guidance of $160 million to $170 million and adjusted EPS of $0.37 to $0.41. Year-to-date order growth stood at 23% with a $726 million backlog.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.91%
Tags
Rhea-AI Summary

Mirion Technologies (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the 2022 Baird Industrial Conference in Chicago, IL. The presentation is scheduled for 11:50 AM ET on Thursday, November 10, 2022. A live webcast will be available at this link and will be archived for two weeks post-event.

Mirion is a premier provider of solutions for the nuclear, defense, medical, and research sectors, employing around 2,800 people globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
conferences
-
Rhea-AI Summary

Mirion Technologies (NYSE: MIR) announced it will release its financial results for Q3 2022 on November 1, 2022, after market close. The company will hold a conference call at 4:30 pm ET on the same day to discuss the results. Interested participants can join the call by dialing 1-877-407-9208 or 1-201-493-6784, or via a live webcast on the company's investor relations website.

Mirion is a leading provider of radiation detection and monitoring solutions, headquartered in Atlanta, GA, and operates in 13 countries with approximately 2,800 employees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
conferences earnings
-
Rhea-AI Summary

On October 21, 2022, Sun Nuclear, a subsidiary of Mirion Technologies (NYSE: MIR), announced its participation in the ASTRO Annual Meeting, showcasing its enhanced Quality Management portfolio. Key exhibits include the SunCHECK Platform and the new SunSCAN 3D System, designed for precise dosimetry and efficient workflows in radiation therapy. Sun Nuclear emphasizes its commitment to patient safety, supporting over 1,600 global clinical users with advanced QA solutions. The event runs from October 23-25, 2022, in San Antonio, Texas, where attendees can participate in demonstrations and networking sessions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.28%
Tags
none
Rhea-AI Summary

Sun Nuclear, a subsidiary of Mirion Technologies (NYSE: MIR), announced the development of new Quality Management solutions in collaboration with Accuray for the Radixact® System with Synchrony®. These innovations will be showcased at the ASTRO Annual Meeting from October 23-25, 2022. Key offerings include the Enhanced Dynamic Platform, designed for precise tumor treatment, and the MotionCHECK™ 3D System, enhancing tumor tracking capabilities. These tools aim to improve patient safety and quality assurance in advanced radiation therapy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.26%
Tags
partnership

FAQ

What is the current stock price of Mirion Technologies (MIR)?

The current stock price of Mirion Technologies (MIR) is $21.77 as of July 18, 2025.

What is the market cap of Mirion Technologies (MIR)?

The market cap of Mirion Technologies (MIR) is approximately 4.7B.
Mirion Technologies Inc

NYSE:MIR

MIR Rankings

MIR Stock Data

4.70B
215.49M
2.38%
89.87%
1.99%
Specialty Industrial Machinery
Measuring & Controlling Devices, Nec
Link
United States
ATLANTA